Wednesday, July 8, 2026

Patent intelligence · US

US 12054475

Substituted heterocycles as aldehyde dehydrogenase inhibitors

granted A61PA61P3/00A61P3/10A61P35/00
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 18
Applicant portfolio 163
Patent details — US 12054475

Quick answer

US 12054475 (Substituted heterocycles as aldehyde dehydrogenase inhibitors) is held by THE TRUSTEES OF PRINCETON UNIVERSITY. Status: granted. Granted Aug 6, 2024. Expires Aug 1, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
30
CPC classes
A61P, A61P3/00, A61P3/10, A61P35/00, A61P9/12

More from THE TRUSTEES OF PRINCETON UNIVERSITY

Related pharmaceutical patents in our USPTO index.

  1. US 12419831

    Hydrocortisone oral liquid formulations

    Eton Pharmaceuticals, Inc. · Expires Sep 18, 2045

    granted
  2. US 12396974

    Ketone ester as a therapeutic treatment of Covid-19 and related viral infections

    KetoneAid · Expires Aug 21, 2045

    granted
  3. US 12357582

    Hydrophobic ion pairing and flash nanoprecipitation for formation of controlled-release nanocarrier formulations

    THE TRUSTEES OF PRINCETON UNIVERSITY · Expires Jul 10, 2045

    granted
  4. US 12343324

    Dihydromyricetin hot melt extrusion formulations and methods for forming them

    THE TRUSTEES OF PRINCETON UNIVERSITY · Expires Jun 26, 2045

    granted
  5. US 12329816

    Immunotherapy with metabolic enzyme expression

    THE TRUSTEES OF PRINCETON UNIVERSITY · Expires Jun 12, 2045

    granted
  6. US 12209256

    System for protein inactivation and recombinant phages for targeted bacterial killing, infection, biodetection, and as a means of protein extraction

    THE TRUSTEES OF PRINCETON UNIVERSITY · Expires Jan 23, 2045

    granted
  7. US 12195768

    System and method for modulating stress granule assembly

    THE TRUSTEES OF PRINCETON UNIVERSITY · Expires Jan 9, 2045

    granted
  8. US 12186436

    Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents

    THE TRUSTEES OF PRINCETON UNIVERSITY · Expires Jan 2, 2045

    granted

Frequently asked questions

What is US patent 12054475?

US 12054475 (Substituted heterocycles as aldehyde dehydrogenase inhibitors) is held by THE TRUSTEES OF PRINCETON UNIVERSITY. Status: granted. Granted Aug 6, 2024. Expires Aug 1, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 12054475?

THE TRUSTEES OF PRINCETON UNIVERSITY is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 163 pharmaceutical patents for this assignee.

When does US 12054475 expire?

Our index shows an expiration date of Aug 1, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.